These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 21771722)

  • 21. Associations of serum sex steroid hormone and 5α-androstane-3α,17β-diol glucuronide concentrations with prostate cancer risk among men treated with finasteride.
    Kristal AR; Till C; Tangen CM; Goodman PJ; Neuhouser ML; Stanczyk FZ; Chu LW; Patel SK; Thompson IM; Reichardt JK; Hoque A; Platz EA; Figg WD; Van Bokhoven A; Lippman SM; Hsing AW
    Cancer Epidemiol Biomarkers Prev; 2012 Oct; 21(10):1823-32. PubMed ID: 22879203
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Variants in estrogen biosynthesis genes, sex steroid hormone levels, and endometrial cancer: a HuGE review.
    Olson SH; Bandera EV; Orlow I
    Am J Epidemiol; 2007 Feb; 165(3):235-45. PubMed ID: 17110639
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genetic polymorphisms of estrogen receptor alpha, CYP19, catechol-O-methyltransferase are associated with familial prostate carcinoma risk in a Japanese population.
    Suzuki K; Nakazato H; Matsui H; Koike H; Okugi H; Kashiwagi B; Nishii M; Ohtake N; Nakata S; Ito K; Yamanaka H
    Cancer; 2003 Oct; 98(7):1411-6. PubMed ID: 14508827
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association of the steroid synthesis gene CYP11a with polycystic ovary syndrome and hyperandrogenism.
    Gharani N; Waterworth DM; Batty S; White D; Gilling-Smith C; Conway GS; McCarthy M; Franks S; Williamson R
    Hum Mol Genet; 1997 Mar; 6(3):397-402. PubMed ID: 9147642
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Insulin-like growth factors and insulin-like growth factor-binding proteins and prostate cancer risk: results from the prostate cancer prevention trial.
    Neuhouser ML; Platz EA; Till C; Tangen CM; Goodman PJ; Kristal A; Parnes HL; Tao Y; Figg WD; Lucia MS; Hoque A; Hsing AW; Thompson IM; Pollak M
    Cancer Prev Res (Phila); 2013 Feb; 6(2):91-9. PubMed ID: 23315596
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The epidemiology of sex steroid hormones and their signaling and metabolic pathways in the etiology of prostate cancer.
    Platz EA; Giovannucci E
    J Steroid Biochem Mol Biol; 2004 Nov; 92(4):237-53. PubMed ID: 15663987
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serum Retinol and Carotenoid Concentrations and Prostate Cancer Risk: Results from the Prostate Cancer Prevention Trial.
    Nash SH; Till C; Song X; Lucia MS; Parnes HL; Thompson IM; Lippman SM; Platz EA; Schenk J
    Cancer Epidemiol Biomarkers Prev; 2015 Oct; 24(10):1507-15. PubMed ID: 26269564
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association of androgen metabolism gene polymorphisms with prostate cancer risk and androgen concentrations: Results from the Prostate Cancer Prevention Trial.
    Price DK; Chau CH; Till C; Goodman PJ; Leach RJ; Johnson-Pais TL; Hsing AW; Hoque A; Parnes HL; Schenk JM; Tangen CM; Thompson IM; Reichardt JK; Figg WD
    Cancer; 2016 Aug; 122(15):2332-40. PubMed ID: 27164191
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genetic variation in CYP11A1 and StAR in relation to endometrial cancer risk.
    Terry K; McGrath M; Lee IM; Buring J; De Vivo I
    Gynecol Oncol; 2010 May; 117(2):255-9. PubMed ID: 20199803
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Variation in genes involved in the immune response and prostate cancer risk in the placebo arm of the Prostate Cancer Prevention Trial.
    Winchester DA; Till C; Goodman PJ; Tangen CM; Santella RM; Johnson-Pais TL; Leach RJ; Xu J; Zheng SL; Thompson IM; Lucia MS; Lippmann SM; Parnes HL; Dluzniewski PJ; Isaacs WB; De Marzo AM; Drake CG; Platz EA
    Prostate; 2015 Sep; 75(13):1403-18. PubMed ID: 26047319
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inflammation in Benign Prostate Tissue and Prostate Cancer in the Finasteride Arm of the Prostate Cancer Prevention Trial.
    Murtola TJ; Gurel B; Umbehr M; Lucia MS; Thompson IM; Goodman PJ; Kristal AR; Parnes HL; Lippman SM; Sutcliffe S; Peskoe SB; Barber JR; Drake CG; Nelson WG; De Marzo AM; Platz EA
    Cancer Epidemiol Biomarkers Prev; 2016 Mar; 25(3):463-9. PubMed ID: 26715424
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The association between serum sex steroid hormone concentrations and intraprostatic inflammation in men without prostate cancer and irrespective of clinical indication for biopsy in the placebo arm of the Prostate Cancer Prevention Trial.
    Chadid S; Barber JR; Nelson WG; Gurel B; Lucia MS; Thompson IM; Goodman PJ; Stanczyk FZ; Parnes HL; Lippman SM; De Marzo AM; Platz EA
    Prostate; 2020 Aug; 80(11):895-905. PubMed ID: 32506665
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Case-only Methods Identified Genetic Loci Predicting a Subgroup of Men with Reduced Risk of High-grade Prostate Cancer by Finasteride.
    Dai JY; LeBlanc M; Goodman PJ; Lucia MS; Thompson IM; Tangen CM
    Cancer Prev Res (Phila); 2019 Feb; 12(2):113-120. PubMed ID: 30538099
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A polymorphism of the 5 alpha-reductase gene and its association with prostate cancer: a case-control analysis.
    Kantoff PW; Febbo PG; Giovannucci E; Krithivas K; Dahl DM; Chang G; Hennekens CH; Brown M; Stampfer MJ
    Cancer Epidemiol Biomarkers Prev; 1997 Mar; 6(3):189-92. PubMed ID: 9138662
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Polymorphic markers in the SRD5A2 gene and prostate cancer risk: a population-based case-control study.
    Hsing AW; Chen C; Chokkalingam AP; Gao YT; Dightman DA; Nguyen HT; Deng J; Cheng J; Sesterhenn IA; Mostofi FK; Stanczyk FZ; Reichardt JK
    Cancer Epidemiol Biomarkers Prev; 2001 Oct; 10(10):1077-82. PubMed ID: 11588134
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of androgen metabolism genes CYP1B1, PSA/KLK3, and CYP11alpha in prostate cancer risk and aggressiveness.
    Cicek MS; Liu X; Casey G; Witte JS
    Cancer Epidemiol Biomarkers Prev; 2005 Sep; 14(9):2173-7. PubMed ID: 16172228
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CYP19 TCT tri-nucleotide Del/Del genotype is a susceptibility marker for prostate cancer in a Taiwanese population.
    Huang YC; Chen M; Lin MW; Chung MY; Chang YH; Huang WJ; Wu TT; Hsu JM; Yang S; Chen YM
    Urology; 2007 May; 69(5):996-1000. PubMed ID: 17482958
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CYP19A1 genetic variation in relation to prostate cancer risk and circulating sex hormone concentrations in men from the Breast and Prostate Cancer Cohort Consortium.
    Travis RC; Schumacher F; Hirschhorn JN; Kraft P; Allen NE; Albanes D; Berglund G; Berndt SI; Boeing H; Bueno-de-Mesquita HB; Calle EE; Chanock S; Dunning AM; Hayes R; Feigelson HS; Gaziano JM; Giovannucci E; Haiman CA; Henderson BE; Kaaks R; Kolonel LN; Ma J; Rodriguez L; Riboli E; Stampfer M; Stram DO; Thun MJ; Tjønneland A; Trichopoulos D; Vineis P; Virtamo J; Le Marchand L; Hunter DJ
    Cancer Epidemiol Biomarkers Prev; 2009 Oct; 18(10):2734-44. PubMed ID: 19789370
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Variants in hormone biosynthesis genes and risk of endometrial cancer.
    Olson SH; Orlow I; Bayuga S; Sima C; Bandera EV; Pulick K; Faulkner S; Tommasi D; Egan D; Roy P; Wilcox H; Asya A; Modica I; Asad H; Soslow R; Zauber AG
    Cancer Causes Control; 2008 Nov; 19(9):955-63. PubMed ID: 18437511
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A tetranucleotide repeat polymorphism in CYP19 and breast cancer risk.
    Haiman CA; Hankinson SE; Spiegelman D; De Vivo I; Colditz GA; Willett WC; Speizer FE; Hunter DJ
    Int J Cancer; 2000 Jul; 87(2):204-10. PubMed ID: 10861475
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.